Treatment options for hepatobiliary and pancreatic cancer
Document Type
Conference Proceeding
Publication Date
1-1-2007
Journal
Mayo Clinic Proceedings
Volume
82
Issue
5
DOI
10.4065/82.5.628
Abstract
Hepatobiliary and pancreatic cancers account for 4% of all cancers in the United States. Traditionally, these cancers have had a high mortality rate and have been poorly responsive to therapy. Because of a growing number of treatment options, patients are now living longer. For hepatocellular carcinoma, a broad number of treatment options are available, including surgery, ablation, embolization, systemic therapy, and liver transplantation. Treatment options for cholangiocarcinoma include surgery, systemic therapy, and liver transplantation. For pancreatic cancer, surgery, radiation, and systemic therapy all have potential roles. This review provides an updated summary of diagnosis and assessment together with treatment options for this group of cancers. © 2007 Mayo Foundation for Medical Education and Research.
APA Citation
Alberts, S., Gores, G., Kim, G., Roberts, L., Kendrick, M., Rosen, C., Chari, S., & Martenson, J. (2007). Treatment options for hepatobiliary and pancreatic cancer. Mayo Clinic Proceedings, 82 (5). http://dx.doi.org/10.4065/82.5.628